Health Canada drug identification number

DIN 00393444 — ROFACT 150 MG

ROFACT is a capsule of Rifampin marketed by BAUSCH HEALTH, CANADA INC.. The full Rifampin monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
00393444
Brand name
ROFACT
Active ingredient
Rifampin
Strength
150 MG
Dosage form
CAPSULE
Route
ORAL
Manufacturer
BAUSCH HEALTH, CANADA INC.
Health Canada status
MARKETED
Drug class
Rifamycin antibiotic (antituberculosis agent)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Rifampin products

DINBrandStrengthFormManufacturerStatus
00343617 ROFACT 300 MG CAPSULE BAUSCH HEALTH, CANADA INC. MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.